For more information on the potential use of GLP-1 in addiction treatment, you can explore sources such as Frontiers in Neuroscience and Diabetes, Obesity, and Metabolism
In vitro studies demonstrated that treatment with liraglutide or exendin-4 significantly attenuated oxidative stress and cellular apoptosis in SH-SY5Y cells exposed to methylglyoxal or high glucose, which mimicked the pathophysiological conditions of diabetic neuropathy [79, 80]
The main limitation is that many offerings are compounded, so consistency depends on pharmacy quality
Still, caution is required because the adoption of general medical treatments into psychiatry (for example, insulin therapy) has sometimes led to deleterious consequences for patients
As noted in most testimonials, its true that the majority of patients experience some side effects to varying degrees